25 August 2017 - Self-management and self-discipline are the keys to controlling exorbitant drug-pricing practices, former pharmaceutical executive Fred Hassan told CNBC.
Self-management and self-discipline are the keys to controlling exorbitant drug-pricing practices, veteran pharmaceutical executive Fred Hassan told CNBC on Thursday.
That, along with leadership like Allergan CEO Brent Saunders starting his social contract with patients, is the way to ensure prices remain low while maintaining the free-price environment that fosters innovation, he said in an interview on "Power Lunch."